[Stenting in superficial femoral artery and usCRP: Multicentric study SAFE in 255 patients]
| Autor: | Jean-Paul, Beregi, Bertrand, Lehalle, Jean-Marie, Cardon, Jean-Christophe, Pillet, Alain, Chabanier, Maxime, Sibé, Pascal, Aubry, Patrice, de Cassin, Jean-Bernard, Raffin, Bruno, Lecointre, Hélène, Vernhet |
|---|---|
| Jazyk: | francouzština |
| Rok vydání: | 2009 |
| Předmět: |
Adult
Aged 80 and over Male Leg Angioplasty Angiography Arterial Occlusive Diseases Thrombosis Intermittent Claudication Middle Aged Prosthesis Failure C-Reactive Protein Ischemia Recurrence Risk Factors Alloys Humans Female Stents Prospective Studies Tomography X-Ray Computed Magnetic Resonance Angiography Vascular Patency Aged Follow-Up Studies |
| Zdroj: | Presse medicale (Paris, France : 1983). 39(12) |
| ISSN: | 2213-0276 |
| Popis: | To evaluate mid-term primary patency of the femoral artery stenting in correlation with usCRP level and characteristics of the population, morphological aspect of the lesions and interventional techniques.Patients were prospectively included in a multicenter study (18 centers in France) after stenting (SMART, Cordis JohnsonJohnson, Issy-les-Moulineaux, France) of the superficial femoral artery (SFA). Inclusion and exclusion criteria were based on recommendations and every day practice of the centers.Thus 255 patients (183 men; mean age: 69 years; range 44-92) were included. Technical success of the SFA stenting was 100% without any complications and primary angiographic success 97%. usCRP level increased significantly (p 0.05) between before and 24h after SFA stenting. In the subgroup of patients without initial inflammation (n = 157), usCRP increased significantly (p 0.05) in the group of patient with initial thrombosis and additional intervention (graft, amputation, angioplasty on other arterial bed) in the same procedure compared to the remaining patients. Restenosis rate was 12.4% (26/209 patients) at 7 ± 2 months. Before stenting, usCRP level was not predictive of a restenosis, whereas after stenting, an increase of the 24h usCRP level was significantly higher in the subgroup of patient with an occlusion at mid-term (8 patients; p 0.05).This study demonstrated good patency at 7 months of SFA stenting with nitinol SMART with an increase of the usCRP level 24h after stenting in favour of the presence of an occlusion at mid-term follow-up. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect